Works matching IS 00070920 AND DT 2019 AND VI 121 AND IP 4

Results: 12
    1
    2
    3
    4
    5
    6
    7

    Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trial.

    Published in:
    British Journal of Cancer, 2019, v. 121, n. 4, p. 318, doi. 10.1038/s41416-019-0517-3
    By:
    • Veitch, Zachary W.;
    • Cescon, David W.;
    • Denny, Trisha;
    • Yonemoto, Lisa-Maria;
    • Fletcher, Graham;
    • Brokx, Richard;
    • Sampson, Peter;
    • Li, Sze-Wan;
    • Pugh, Trevor J.;
    • Bruce, Jeffrey;
    • Bray, Mark R.;
    • Slamon, Dennis J.;
    • Mak, Tak W.;
    • Wainberg, Zev A.;
    • Bedard, Philippe L.
    Publication type:
    Article
    8
    9
    10

    Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines.

    Published in:
    British Journal of Cancer, 2019, v. 121, n. 4, p. 325, doi. 10.1038/s41416-019-0520-8
    By:
    • Munzone, Elisabetta;
    • Bagnardi, Vincenzo;
    • Campennì, Giuseppe;
    • Mazzocco, Ketti;
    • Pagan, Eleonora;
    • Tramacere, Andrea;
    • Masiero, Marianna;
    • Iorfida, Monica;
    • Mazza, Manuelita;
    • Montagna, Emilia;
    • Cancello, Giuseppe;
    • Bianco, Nadia;
    • Palazzo, Antonella;
    • Cardillo, Anna;
    • Dellapasqua, Silvia;
    • Sangalli, Claudia;
    • Pettini, Greta;
    • Pravettoni, Gabriella;
    • Colleoni, Marco;
    • Veronesi, Paolo
    Publication type:
    Article
    11
    12